| C79H133N21O23S2 | 1809.19 | H-Lys(biotinyl)-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2 | ||
| C69H119N19O21S | 1582.89 | H-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-Ser-Abu-Ser-Tyr-Lys-Lys-NH2 | ||
| C38H68N10O13S | 905.08 | H-Lys-Lys-Glu-Asp-Val-Val-Abu-Cys-OH | ||
| C39H51N7O18S | 937.94 | 291297-58-0 | Mca-Glu-Asp-Ala-Ser-Thr-Pro-Cys-OH | |
| C31H53N9O9 | 695.82 | H-Ser-Abu-Ser-Tyr-Lys-Lys-NH2 | ||
| Abz-Gly-Ala-Lys(Ac)-Ala-Ala-Dap(Dnp)-NH2 | C35H48N12O12 | 828.84 | 761443-02-1 | Abz-Gly-Ala-Lys(Ac)-Ala-Ala-Dap(Dnp)-NH2 |
| Ac-RGK-AMC | C26H38N8O6 | 558.64 | 660846-99-1 | Ac-Arg-Gly-Lys-AMC |
| Ac-RGK(Ac)-AMC | C28H40N8O7 | 600.68 | 660846-97-9 | Ac-Arg-Gly-Lys(Ac)-AMC |
| Ac-GAK(Ac)-AMC | C25H33N5O7 | 515.57 | 577969-56-3 | Ac-Gly-Ala-Lys(Ac)-AMC |
| Ac-GAK-AMC | C23H31N5O6 | 473.53 | Ac-Gly-Ala-Lys-AMC | |
| C38H56N6O7S | 740.97 | Ac-Val-Tyr-Leu-Lys-Ala-SBzl | ||
| C102H143N23O24S | 2107.46 | 400746-50-1 | H-Glu(EDANS)-Val-Tyr-Leu-Lys-Ala-Ser-Gln-Phe-Pro-Ala-Gly-Ile-Lys(DABCYL)-Gly-OH Trifluoroacetate salt |
|
| HSV-1-amide UL 26 Open Reading frame (242-255) | C80H117N21O20S | 1725.01 | H-His-Thr-Tyr-Leu-Gln-Ala-Ser-Glu-Lys-Phe-Lys-Met-Trp-Gly-NH2 | |
| HSV-1 Glycoprotein (gB) (497-507) | C59H91N15O18 | 1298.46 | 148337-11-5 | H-Thr-Ser-Ser-Ile-Glu-Phe-Ala-Arg-Leu-Gln-Phe-OH |
| (Nle253)-HSV-1 UL 26 Open Reading frame (238-257) | C102H152N26O29 | 2206.49 | 165174-61-8 | H-Gly-Ile-Ala-Gly-His-Thr-Tyr-Leu-Gln-Ala-Ser-Glu-Lys-Phe-Lys-Nle-Trp-Gly-Ala-Glu-OH |
| C26H42N6O6 | 534.66 | 197970-37-9 | H-Leu-Val-Leu-Ala-pNA | |
| C70H105N23O27 | 1700.74 | Mca-γ-Abu-Asn-Arg-Leu-Glu-Ala-Ser-Ser-Arg-Ser-Ser-Lys(Dnp)-NH2 Trifluoroacetate salt |
||
| Hippuryl-Arg-OH | C15H21N5O4 | 335.36 | 744-46-7 | Bz-Gly-Arg-OH |
| Hippuryl-Gly-OH | C11H12N2O4 | 236.23 | 1145-32-0 | Bz-Gly-Gly-OH |
| Hippuryl-Gly-Gly-OH | C13H15N3O5 | 293.28 | 31384-90-4 | Bz-Gly-Gly-Gly-OH |
| Hippuryl-His-Leu-OH | C21H27N5O5 | 429.48 | 31373-65-6 | Bz-Gly-His-Leu-OH |
| Hippuryl-Lys-OH | C15H21N3O4 | 307.35 | 740-63-6 | Bz-Gly-Lys-OH |
| Hippuryl-D-Lys-OH | C15H21N3O4 | 307.35 | 108392-04-7 | Bz-Gly-D-Lys-OH |
| Hippuryl-Lys-Val-OH | C20H30N4O5 | 406.48 | 315229-41-5 | Bz-Gly-Lys-Val-OH |
| Hippuryl-Phe-OH | C18H18N2O4 | 326.35 | 744-59-2 | Bz-Gly-Phe-OH |
| Hippuryl-Phe-Arg-OH | C24H30N6O5 | 482.54 | 73167-83-6 | Bz-Gly-Phe-Arg-OH |
| Bivalirudin, BG 8967, Hirulog, Hirulog I | C98H138N24O33 | 2180.32 | 128270-60-0 | H-D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH |
| Acetyl-Hirudin (53-65) (sulfated), Hirugen | C72H100N14O32S | 1705.73 | 348603-19-0 | Ac-Asp-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO3H)-Leu-Gln-OH |
| Hirudin (54-65) (desulfated) | C66H93N13O25 | 1468.54 | 113274-56-9 | H-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln-OH |
| Hirudin (54-65) (sulfated) | C66H93N13O28S | 1548.60 | 109528-49-6 | H-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO3H)-Leu-Gln-OH |
| Acetyl-Hirudin (54-65) (sulfated) | C68H95N13O29S | 1590.64 | 125441-00-1 | Ac-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO3H)-Leu-Gln-OH |
| Acetyl-Hirudin (55-65) (desulfated) | C66H92N12O25 | 1453.52 | 113274-57-0 | Ac-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln-OH |
| Hirudin (55-65) (sulfated) | C64H90N12O27S | 1491.55 | 109528-50-9 | H-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO3H)-Leu-Gln-OH |
| Acetyl-Hirudin (55-65) (sulfated) | C66H92N12O28S | 1533.59 | 125441-01-2 | Ac-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO3H)-Leu-Gln-OH |
| Succinyl-(Pro58,D-Glu65)-Hirudin (56-65) (sulfated) | C64H88N10O26S | 1445.52 | 131791-98-5 | Suc-Phe-Glu-Pro-Ile-Pro-Glu-Glu-Tyr(SO3H)-Leu-D-Glu-OH |
| Histatin-5 | C133H195N51O33 | 3036.34 | 104339-66-4 | H-Asp-Ser-His-Ala-Lys-Arg-His-His-Gly-Tyr-Lys-Arg-Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr-OH Trifluoroacetate salt |
| Histatin-8, HIP, Hemagglutination-Inhibiting Peptide | C70H99N25O17 | 1562.71 | 127637-03-0 | H-Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr-OH |
| SMCX (963-973) (human) | C48H81N13O18 | 1128.25 | H-Ser-Pro-Ala-Val-Asp-Lys-Ala-Gln-Ala-Glu-Leu-OH | |
| SMCY (950-960) (human) | C49H85N15O18 | 1172.30 | H-Ser-Pro-Ser-Val-Asp-Lys-Ala-Arg-Ala-Glu-Leu-OH | |
| Ac-Ser-Gln-Asn-Tyr-OH | C23H32N6O10 | 552.54 | 129521-68-2 | Ac-Ser-Gln-Asn-Tyr-OH |
| C25H37N5O8 | 535.60 | 137372-00-0 | Ac-Thr-Leu-Asn-Phe-OH | |
| C36H49N7O11 | 755.83 | 150626-30-5 | Ac-Thr-Val-Ser-Phe-Asn-Phe-OH | |
| Anthranilyl-HIV Protease Substrate | C43H65N13O11 | 940.07 | 133233-38-2 | Abz-Thr-Ile-Nle-p-nitro-Phe-Gln-Arg-NH2 |
| Anthranilyl-HIV Protease Substrate III | C65H100N20O17 | 1433.63 | 138668-80-1 | Abz-His-Lys-Ala-Arg-Val-Leu-p-nitro-Phe-Glu-Ala-Nle-Ser-NH2 |
| Anthranilyl-HIV Protease Substrate IV | C56H88N16O14 | 1209.41 | 141223-69-0 | Abz-Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 |
| Anthranilyl-HIV Protease Substrate V | C50H76N14O13 | 1081.24 | 210644-48-7 | Abz-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 |
| Anthranilyl-HIV Protease Substrate VI | C47H71N13O12 | 1010.16 | 210644-49-8 | Abz-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 |
| C93H156N26O19S2 | 2006.56 | 118720-30-2 | H-Lys-Arg-Trp-Ile-Ile-Leu-Gly-Leu-Asn-Lys-Ile-Val-Arg-Met-Tyr-Cys-OH | |
| (Cys(Bzl)84)-CD4 (81-92) | C69H102N14O26S | 1575.71 | 123380-68-7 | H-Thr-Tyr-Ile-Cys(Bzl)-Glu-Val-Glu-Asp-Gln-Lys-Glu-Glu-OH |
| (Cys(Bzl)84,Glu(OBzl)85)-CD4 (81-92) | C76H108N14O26S | 1665.84 | H-Thr-Tyr-Ile-Cys(Bzl)-Glu(OBzl)-Val-Glu-Asp-Gln-Lys-Glu-Glu-OH |
